Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

All AbbVie's CEO wanted for Christmas was Cerevel—oh, and ImmunoGen, too
Fierce Biotech
Mon, 01/8/24 - 11:30 am
Tags:
AbbVie, Richard Gonzalez, Cerevel Therapeutics, M&A
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
Tags:
M&A, JPMHC 2024, AbbVie, AstraZeneca, Bristol Myers Squibb, Carmot Therapeutics, Eli Lilly
AbbVie is big pharma’s first mover in ‘in situ’ cell therapy
Pharmaphorum
Fri, 01/5/24 - 09:48 am
Tags:
AbbVie, Umoja Biopharma, cell therapy, in situ cell therapy
CVS to Remove AbbVie’s Humira from Reimbursement Lists, Cover Biosimilars
BioSpace
Thu, 01/4/24 - 10:18 am
Tags:
CVS Caremark, CVS Health, AbbVie, Humira, biosimilars
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
Tags:
AbbVie, Immunogen, M&A, antibody-drug conjugate
AbbVie lawsuit says rival Adcentrx stole anti-cancer secrets
Reuters
Wed, 12/20/23 - 06:39 pm
Tags:
legal, AbbVie, Adcentrx, trade secrets
US consumer group seeks stronger warnings on Botox, similar treatments
Reuters
Tue, 12/12/23 - 10:02 am
Tags:
Public Citizen, FDA, Botox, AbbVie, Revance Therapeutics, Daxxify, Evolus, Jeuveau, Supernus Pharmaceuticals, Myobloc, Galderma, Dysport
AbbVie and Genmab report data from follicular lymphoma antibody trial
Clinical Trials Arena
Mon, 12/11/23 - 09:59 am
Tags:
AbbVie, Genman, clinical trials, epcoritamab, bispecific antibodies, relapsed or refractory follicular lymphoma
FTC warns pharma companies on excessive drug patenting
Medical Marketing and Media
Fri, 12/8/23 - 10:05 am
Tags:
FTC, AbbVie, AstraZeneca, Teva Pharmaceutical, patents
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy: 'This acquisition is not anti-competitive.'
Fierce Biotech
Thu, 12/7/23 - 11:08 pm
Tags:
AbbVie, Cerevel Therapeutics, M&A, Richard Gonzalez, FTC, anticompetitive practices
AbbVie to buy Cerevel in $8.7B bet on brain drugs
BioPharma Dive
Wed, 12/6/23 - 09:23 pm
Tags:
AbbVie, Cerevel Therapeutics, M&A, Neuroscience
Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System
Forbes
Mon, 12/4/23 - 10:14 am
Tags:
Humira, AbbVie, biosimilars, FDA
J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey
Fierce Pharma
Sun, 12/3/23 - 09:36 pm
Tags:
JNJ, AbbVie, Sanofi, Turkey, competition
AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval
BioSpace
Fri, 12/1/23 - 11:23 am
Tags:
AbbVie, Teliso-V, antibody-drug conjugate, non-small cell lung cancer
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Medical Marketing and Media
Fri, 12/1/23 - 09:43 am
Tags:
biotech stocks, AbbVie, Immunogen, M&A
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
Tags:
AbbVie, M&A, antibody-drug conjugate, Immunogen, Elahere, ovarian cancer
AbbVie cues up filing for c-Met ADC in lung cancer
Pharmaphorum
Wed, 11/29/23 - 12:00 pm
Tags:
AbbVie, Teliso-V, clinical trials, lung cancer
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
Wed, 11/22/23 - 11:39 am
Tags:
AbbVie, Rinvoq, patents, legal, Sandoz, Sun Pharma, Intas Pharmaceuticals
AbbVie’s Migraine Drug Ubrelvy Scores Victory in Phase III Study
BioSpace
Fri, 11/17/23 - 10:00 am
Tags:
AbbVie, Ubrelvy, ubrogepant, migraines, clinical trials
Skyrizi goes sky-high in October among Rx, OTC pharma brands
Medical Marketing and Media
Sun, 11/12/23 - 09:19 pm
Tags:
Boehringer Ingelheim, AbbVie, Skyrizi, DTC advertising, pharma advertising

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.